Remy W
Z Hautkr. 1977 Apr 15;52(8):470-4.
Since quite some time relapsing herpes simplex virus infections of the skin are clinically successfully treated with a heat-inactivated vaccine Lupidon G and Lupidon H respectively, although nothing is known as yet regarding the working principle of this therapy, which bases on immunological reflections. It was, therefore, examined by the complement fixing and neutralizing antibodies against herpes simplex virus of 11 patients and 3 control individuals if repeated injections of this vaccine cause alterations of the specific antibody titer. Skin tests were made in addition with 9 patient prior to and 8 weeks after therapy at the earliest. During the entire eamination period of at least 8 weeks up to 9 months the complement fixing as well as the neutralizing antibody titer remained practically constant and in none of the examined cases the skin tests caused any reaction. Since it is, however, known, e.g. from the examinations by Lehner, that seropositive individuals reacta to herpes virus with symptoms of an allergy of the delayed type, is must particularly be considered in furture examinations on the working mechanism of Lupidon that the Lupidon solutions for intracutaneous testing must be of considerably higher concentration. The questition of the site of action of Lupidon at the interferon mechanism remains pending in addition.
一段时间以来,皮肤复发性单纯疱疹病毒感染分别用热灭活疫苗卢皮东G和卢皮东H进行临床治疗取得了成功,尽管对于这种基于免疫学思考的治疗方法的作用原理尚不清楚。因此,对11名患者和3名对照个体进行了检测,以确定反复注射这种疫苗是否会导致抗单纯疱疹病毒的补体结合抗体和中和抗体效价发生变化。此外,对9名患者在治疗前以及最早在治疗后8周进行了皮肤试验。在至少8周长达9个月的整个检查期间,补体结合抗体效价和中和抗体效价实际上保持恒定,在所检查的病例中,皮肤试验均未引起任何反应。然而,例如从莱纳的检查中可知,血清反应阳性个体对疱疹病毒会出现迟发型过敏症状,因此在未来关于卢皮东作用机制的研究中,必须特别考虑用于皮内试验的卢皮东溶液浓度必须显著更高。此外,卢皮东在干扰素机制方面的作用位点问题仍未解决。